Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil requirements in deep vs moderate NMB during laparoscopic herniorrhaphy
NCT04022733Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of remifentanil (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Remifentanil Infusion Rate at 30 minutes. Started Oct 2019; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT04022733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022733.